We are live on
!
Find out more
TAM
Tiverton Asset Management Portfolio holdings
AUM
$2.88B
1-Year Est. Return
5.6%
This Fund
S&P 500
This Quarter
Est. Return
+1.35%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
–
AUM
$2.94B
AUM Growth
-$211M
(-6.7%)
Cap. Flow
-$197M
Cap. Flow
% of AUM
-6.7%
Top 10 Holdings %
Top 10 Hldgs %
25.94%
Holding
161
New
21
Increased
14
Reduced
124
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta Japan Equity ETF
GSJY
|
+$22.9M |
| 2 |
Goldman Sachs ActiveBeta Europe Equity ETF
GSEU
|
+$22.7M |
| 3 |
Meta Platforms (Facebook)
META
|
+$12.2M |
| 4 |
Marriott International
MAR
|
+$11.8M |
| 5 |
Palo Alto Networks
PANW
|
+$9.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$19.6M |
| 2 |
Apple
AAPL
|
+$14.4M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$12.3M |
| 4 |
Kirby Corp
KEX
|
+$9.55M |
| 5 |
Henry Schein
HSIC
|
+$9.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.04% |
| 2 | Technology | 18.89% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Industrials | 12.93% |
| 5 | Financials | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Myriad Genetics
MYGN
$307M
| $6.84M | 0.23% |
182,774
-17,226
| -9% | -$649K |
|
|
102
State Street SPDR S&P Regional Banking ETF
KRE
$4.65B
| $6.19M | 0.21% |
164,549
-335,451
| -67% | -$12.3M |
|
103
Axos Financial
AX
$5.74B
| $6.05M | 0.21% |
+283,621
| New | +$5.14M |
|
104
ASML
ASML
$663B
| $5.97M | 0.2% |
59,444
-5,556
| -9% | -$501K |
|
105
Patrick Industries
PATK
$2.9B
| $5.81M | 0.2% |
287,867
-27,133
| -9% | -$473K |
|
|
VCRA
106
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $5.54M | 0.19% |
434,089
-143,421
| -25% | -$1.99M |
|
|
MDVN
107
DELISTED
MEDIVATION, INC.
MDVN
| $5.28M | 0.18% |
114,902
-25,098
| -18% | -$910K |
|
|
LUMO
108
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $5.2M | 0.18% |
31,747
-2,981
| -9% | -$604K |
|
|
OXFD
109
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $5M | 0.17% |
504,000
-111,531
| -18% | -$1.14M |
|
|
PFPT
110
DELISTED
Proofpoint, Inc.
PFPT
| $4.94M | 0.17% |
91,855
+66,855
| +267% | +$3.41M |
|
111
LivaNova
LIVN
$4.16B
| $4.93M | 0.17% |
91,387
-33,613
| -27% | -$1.87M |
|
112
Zions Bancorporation
ZION
$10.3B
| $4.84M | 0.16% |
200,105
+100,105
| +100% | +$2.3M |
|
|
NXTM
113
DELISTED
NxStage Medical Inc.
NXTM
| $4.73M | 0.16% |
315,754
-159,246
| -34% | -$2.67M |
|
|
EXAM
114
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $4.46M | 0.15% |
150,789
-14,211
| -9% | -$386K |
|
|
ULTI
115
DELISTED
Ultimate Software Group Inc
ULTI
| $4.42M | 0.15% |
+22,847
| New | +$3.98M |
|
116
Q2 Holdings
QTWO
$3.99B
| $4.42M | 0.15% |
183,712
-16,288
| -8% | -$350K |
|
117
Artisan Partners
APAM
$3.11B
| $4.25M | 0.14% |
137,783
-12,217
| -8% | -$357K |
|
|
BLUE
118
DELISTED
bluebird bio
BLUE
| $3.96M | 0.13% |
+7,188
| New | +$4.41M |
|
119
Syndax Pharmaceuticals
SNDX
$1.78B
| $3.85M | 0.13% |
+288,750
| New | +$3.63M |
|
|
OTIC
120
DELISTED
Otonomy, Inc.
OTIC
| $3.56M | 0.12% |
238,894
-52,300
| -18% | -$822K |
|
121
EXL Service
EXLS
$5.3B
| $3.55M | 0.12% |
342,705
-32,295
| -9% | -$297K |
|
122
Teladoc Health
TDOC
$1.29B
| $3.54M | 0.12% |
368,477
+218,477
| +146% | +$3.1M |
|
|
TYPE
123
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $3.3M | 0.11% |
137,783
-12,217
| -8% | -$285K |
|
124
Atara Biotherapeutics
ATRA
$74.7M
| $3.24M | 0.11% |
6,804
-601
| -8% | -$271K |
|
125
Veeva Systems
VEEV
$37.3B
| $3.2M | 0.11% |
127,941
-12,059
| -9% | -$295K |
|
Similar funds
TAM
RCM
NA
FCM
STMM
CC
CA
BA
Tiverton Asset Management's Q1 2016 Portfolio in Review
As of Q1 2016, Tiverton Asset Management held 161 positions worth $2.94B, down 6.7% from $3.15B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Tiverton Asset Management withdrew a net $197M in Q1 2016, closing 2 positions and reducing 124 holdings. Its most notable exit was Waddell & Reed Financial, Inc., an estimated $3.45M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Tiverton Asset Management opened a new position in Goldman Sachs ActiveBeta Japan Equity ETF worth $23M.
- Tiverton Asset Management's largest Q1 2016 buy was Goldman Sachs ActiveBeta Japan Equity ETF: 875,000 shares worth $23M.
- Tiverton Asset Management added most to Meta Platforms (Facebook) in Q1 2016, an estimated $12.2M increase.
- Tiverton Asset Management's biggest Q1 2016 reduction was Twenty-First Century Fox, Inc. Class A, cutting an estimated $19.6M.
- Tiverton Asset Management fully exited Waddell & Reed Financial, Inc. in Q1 2016, selling an estimated $3.45M.
- Tiverton Asset Management's ten largest holdings make up 26% of its $2.94B portfolio in Q1 2016.
- Tiverton Asset Management opened 21 new positions and closed 2 in Q1 2016.
- Tiverton Asset Management's portfolio value fell 6.7% quarter-over-quarter to $2.94B.
Based on Tiverton Asset Management's 13F filing for Q1 2016, filed 13 May 2016.